Publication: Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation
| dc.contributor.author | Wasana Prasitsuebsai | en_US |
| dc.contributor.author | Tim R. Cressey | en_US |
| dc.contributor.author | Edmund Capparelli | en_US |
| dc.contributor.author | Nirun Vanprapar | en_US |
| dc.contributor.author | Keswadee Lapphra | en_US |
| dc.contributor.author | Kulkanya Chokephaibulkit | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.contributor.other | Chiang Mai University | en_US |
| dc.contributor.other | Harvard School of Public Health | en_US |
| dc.contributor.other | University of California, San Diego | en_US |
| dc.date.accessioned | 2018-06-11T05:13:49Z | |
| dc.date.available | 2018-06-11T05:13:49Z | |
| dc.date.issued | 2012-04-01 | en_US |
| dc.description.abstract | We assessed the pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children while they were receiving nevirapine-containing fixed-dose combination tablets with rifampicin-based tuberculosis treatment and after discontinuation. The median age (range) was 9.7 (4.4-11.7) years. The nevirapine area under the concentration versus time curve from 0 to12 hours and trough concentration with rifampicin were 85.3 (40.5-170.7) mg.h/mL and 6.4 (3.00-13.27) mg/mL, respectively, providing adequate exposure. © 2012 by Lippincott Williams & Wilkins. | en_US |
| dc.identifier.citation | Pediatric Infectious Disease Journal. Vol.31, No.4 (2012), 389-391 | en_US |
| dc.identifier.doi | 10.1097/INF.0b013e3182401c41 | en_US |
| dc.identifier.issn | 15320987 | en_US |
| dc.identifier.issn | 08913668 | en_US |
| dc.identifier.other | 2-s2.0-84858800794 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/14881 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84858800794&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84858800794&origin=inward | en_US |